Domov › Rakovina (všetky typy) › Texas › Houston
Klinické štúdie Rakovina (všetky typy) v meste Houston, TX
121 štúdií pre Rakovina (všetky typy) hľadá účastníkov v zariadeniach v meste Houston a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Prebieha náborFáza 2/3
- The University of Texas MD Anderson Cancer Center /ID# 275107, Houston
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Prebieha náborFáza 1
- The University of Texas - MD Anderson Cancer Center, Houston
A Study of PHN-012 in Patients With Advanced Solid Tumors
Prebieha náborFáza 1
- PHN-012-001 Site, Houston
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Prebieha náborObservačná štúdia
- The University of Texas M.D. Anderson Cancer Center, Houston
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
Prebieha náborFáza 1
- MD Anderson Cancer Center, Houston
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
Prebieha náborFáza 3
- Investigative Site, Houston
A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
Prebieha náborFáza 2
- Baylor College of Medicine Medical Center ( Site 0004), Houston
- Harris Health System ( Site 0040), Houston
A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors
Prebieha náborFáza 1
- MD Anderson Cancer Center, Houston
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
Prebieha náborFáza 1/2
- University of Texas M.D. Anderson Cancer Center ( Site 4007), Houston
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Prebieha náborFáza 2/3
- Houston Methodist Hospital, Houston
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
Prebieha náborFáza 1
- MD Anderson Cancer Center, Houston
A Study of JNJ-1761981 in Participants With Solid Tumors
Prebieha náborFáza 1
- MD Anderson Cancer Center, Houston
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Prebieha náborFáza 3
- Oncology Consultants PA, Houston
- University of Texas MD Anderson Cancer Center, Houston
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
Prebieha náborFáza 1
- MD Anderson Cancer Center, Houston
- NEXT Oncology, Houston
Pilot Study of Management of Facial Paralysis in the Oncologic Patient: Nerve Transfer Techniques to Improve Facial Function and Quality of Life
Prebieha nábor
- The University of Texas M. D. Anderson Cancer Center, Houston
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Prebieha náborFáza 3
- Houston Methodist Cancer Center, Houston
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Prebieha náborFáza 3
- Quetzal Site 6, Houston
Intratumoral N17350 in Advanced Solid Tumors
Prebieha náborFáza 1/2
- The University of Texas MD Anderson Cancer Center, Houston
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Prebieha náborFáza 3
- The University of Texas MD Anderson Cancer Center /ID# 280070, Houston
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Prebieha náborFáza 2
- The University of Texas MD Anderson Cancer Center, Houston
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Prebieha náborFáza 1/2
- MD Anderson, Houston
Bone Marrow Imaging and Clinical Outcomes Across Hematologic, Oncologic, and Other Relevant Conditions
Prebieha náborObservačná štúdia
- UT MD Anderson Cancer Center, Houston
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Prebieha náborFáza 2/3
- The University of Texas Health Science Center at Houston, Houston
- University of Texas- MD Anderson, Houston
Perceptions of Hospital Care at Home for Patients With Cancer: A Qualitative Study of Cancer Providers, Patients and Caregivers.
Prebieha náborObservačná štúdia
- M D Anderson Cancer Center, Houston
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
Prebieha náborFáza 1/2
- University of Texas-MD Anderson Cancer Center ( Site 3007), Houston
Statins to Prevent Cancer Associated Blood Clots
Prebieha náborFáza 4
- The University of Texas MD Anderson Cancer Center, Houston
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Prebieha náborFáza 2
- The University of Texas MD Anderson Cancer Center, Houston
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
Prebieha náborFáza 2
- The University of Texas M. D. Anderson Cancer Center, Houston
A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
Prebieha náborFáza 1/2
- The University of Texas Md Anderson Cancer Center, Houston
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
Prebieha náborFáza 1/2
- Research Site, Houston
A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001)
Prebieha náborFáza 1
- Houston Methodist Hospital ( Site 0103), Houston
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
Prebieha náborFáza 1/2
- NEXT Oncology ( Site 1011), Houston
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
Prebieha náborFáza 1
- Investigational Site Number: 401, Houston
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Prebieha náborFáza 1
- MD Anderson Cancer Center - University of Texas, Houston
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Prebieha náborFáza 1
- UT MD Anderson, Houston
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
Prebieha náborFáza 1/2
- University of Texas MD Anderson Cancer Center, Houston
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Prebieha náborFáza 3
- Houston Methodist Hospital, Houston
- University of Texas MD Anderson Cancer Center, Houston
- Lumi Research, Houston
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
Prebieha náborFáza 2
- Kelsey-Seybold Clinic, Houston
Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus
Prebieha náborFáza 2
- M D Anderson Cancer Center, Houston
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Prebieha náborFáza 1
- MD Anderson Cancer Center, Houston
A Prospective Single Center, Single Arm, Single-institution Registry That Aims to Assess the Safety and Quality of Life Benefits of Computer-assisted Vacuum Thrombectomy (CAVT) in the Treatment of Cancer Patients With Intermediate Risk Pulmonary Embolism (PE)
Prebieha nábor
- The University of Texas M. D. Anderson Cancer Center, Houston
PREDICTT Clinical Trial: Prospective Evaluation Of Pressure-Enabled Delivery And Alterations In CT-Based Tumor-To-Normal Liver Ratio And Tumor Dose Using The Trinav Infusion System
Prebieha nábor
- The University of Texas M. D. Anderson Cancer Center, Houston
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Prebieha náborFáza 1
- The University of Texas MD Anderson Cancer Center, Houston
Phase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High Tumor Burden Follicular Lymphoma
Prebieha náborFáza 2
- M D Anderson Cancer Center, Houston
ORB-021 In Patients With Advanced Solid Tumors
Prebieha náborFáza 1
- MDAC, Houston
Project: Every Child for Younger Patients With Cancer
Prebieha náborObservačná štúdia
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
- UT MD Anderson Cancer Center, Houston
Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
Prebieha náborFáza 3
- Houston Metro Urology, Houston
Abatacept in Immune Checkpoint Inhibitor Myocarditis
Prebieha náborFáza 3
- MD Anderson Cancer Center, Houston
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Prebieha náborFáza 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Development of Brief Positive Affect Treatment (PAT) for Caregivers of Patients With Advanced Cancer
Prebieha náborObservačná štúdia
- The University of Texas M. D. Anderson Cancer Center, Houston
Psycho-Spiritual Management for Patients With Advanced Cancer and Their Family Caregivers
Prebieha nábor
- MD Anderson, Houston
Phase 1 Study of JV-394 Autologous Anti-CD94 CAR T for r/r CD94+ T/NK Cell Neoplasms
Prebieha náborFáza 1
- The University of Texas M. D. Anderson Cancer Center, Houston
TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors
Prebieha náborFáza 2
- The University of Texas M. D. Anderson Cancer Center, Houston
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
Prebieha nábor
- The University of Texas M. D. Anderson Cancer Center, Houston
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Prebieha náborFáza 1/2
- The University of Texas, MD Anderson Cancer Center, Houston
Examining the Feasibility and Impact of a Clinic-based Food Farmacy and Digital Culinary Medicine Program Among Cancer Survivors Treated in a Safety Net Hospital
Prebieha nábor
- The University of Texas M. D. Anderson Cancer Center, Houston
Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical Study
Prebieha náborFáza 2
- M D Anderson Cancer Center, Houston
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
Prebieha náborFáza 2
- Texas Childrens Hospital, Houston
- University of Texas MD Anderson Cancer Center, Houston
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Prebieha náborFáza 3
- Houston Methodist Hospital, Houston
- Memorial Hermann Texas Medical Center, Houston
- Methodist Willowbrook Hospital, Houston
- a 1 ďalších
IDOV-Immune for Advanced Solid Tumors
Prebieha náborFáza 1
- MD Anderson Cancer Center, Houston
New Assessment System in Measuring Symptom Distress in Cancer Patients
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- M D Anderson Cancer Center, Houston
Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
Prebieha náborFáza 2
- MD Anderson Cancer Center, Houston
Testing eSCCIP: An eHealth Psychosocial Intervention for English and Spanish Speaking Parents of Children With Cancer
Prebieha náborVítaní zdravých dobrovoľníkov
- MD Anderson Cancer Center, Houston
Decoupling Immunotherapy Toxicity and Cancer Response
Prebieha náborObservačná štúdia
- The University of Texas M. D. Anderson Cancer Center, Houston
A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients
Prebieha náborFáza 3
- M D Anderson Cancer Center, Houston
Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
Prebieha nábor
- M D Anderson Cancer Center, Houston
Long-Term Follow-Up of Recipient of Gene Transfer Research
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- University of Texas MD Anderson Cancer Center, Houston
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
Prebieha náborFáza 1
- Oncology Consultants /ID# 268323, Houston
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Prebieha náborFáza 2
- The University of Texas MD Anderson Cancer Center /ID# 273539, Houston
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Prebieha náborFáza 1/2
- University of Texas MD Anderson Cancer Center, Houston
A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer
Prebieha náborFáza 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Prebieha náborFáza 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Molecular Genetics Studies of Cancer Patients and Their Relatives
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Prebieha náborFáza 1/2
- The University of Texas MD Anderson Cancer Center, Houston
A Multi Center Study of Sexual Toxicities After Radiotherapy
Prebieha náborObservačná štúdia
- M.D. Anderson Cancer Center, Houston
Childhood Cancer Survivor Study
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- M.D. Anderson Cancer Center, Houston
- Texas Children's Hospital, Houston
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Prebieha nábor
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Prebieha náborFáza 1
- Research Site, Houston
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
Prebieha náborFáza 1
- University of Texas MD Anderson Cancer Center /ID# 252004, Houston
A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
Prebieha náborFáza 1
- The University of Texas MD Anderson Cancer Center, Houston
Active Living After Cancer: Implementation Within Be Well Acres Homes
Prebieha nábor
- The University of Texas M. D. Anderson Cancer Center, Houston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Prebieha náborFáza 1/2
- MD Anderson Cancer Center, Houston
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
Prebieha náborFáza 1/2
- University of Texas MD Anderson Cancer Center, Houston
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors
Prebieha náborFáza 1
- MDACC, Houston
Combination Therapy for Cancer Related Fatigue in Patients With Metastatic Cancers
Prebieha náborFáza 2/3
- MD Anderson Cancer Centerr, Houston
Neoadjuvant PD-1 Plus TIGIT Blockade in Patients With Cisplatin-Ineligible Operable High-Risk Urothelial Carcinoma
Prebieha náborFáza 1/2
- M D Anderson Cancer Center, Houston
A Study to Evaluate the Efficacy and Safety of TL118 in Solid Tumors Patients
Prebieha náborFáza 2
- The University of Texas MD Anderson Cancer Center, Houston
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
Prebieha náborFáza 1/2
- MD Anderson Cancer Center, Houston
A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC
Prebieha náborFáza 2
- University of Texas MD Anderson Cancer Center, Houston
Assessment of Functional and Symptom Outcomes for Survivors of Paranasal Sinus, Nasopharyngeal and Skull Base Tumors
Prebieha náborObservačná štúdia
- M D Anderson Cancer Center, Houston
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
Prebieha náborFáza 1
- MD Anderson Cancer Center, Houston
Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases
Prebieha náborFáza 2
- M D Anderson Cancer Center, Houston
Validation of the Screen of Cancer Survivorship - Occupational Therapy Services (SOCS-OTS) Tool for Use in a Physical Medicine Rehabilitation Clinic
Prebieha náborObservačná štúdia
- MD Anderson Cancer Center, Houston
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
Prebieha náborFáza 1
- University of Texas MD Anderson Cancer Center, Houston
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Prebieha náborFáza 1/2
- The University of Texas MD Anderson Cancer Center, Houston
The Cancer Stage Shifting Initiative: Registry and Biorepository to Research and Address Health Disparities in Cancer Care
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- Grace Clinic, Houston
Suprachoroidal Administration in Subjects With Metastases to the Choroid
Prebieha náborFáza 2
- Retina Consultants of Texas, Bellaire · 7 míľ odtiaľ
Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery
Prebieha náborFáza 2
- Houston Methodist Neal Cancer Center, Houston
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Prebieha náborObservačná štúdia
- Md Anderson Cancer Center, Houston
Effectiveness and Performance of an Optical Biopsy Technology for Esophageal Cancer in Brazil and the United States
Prebieha náborFáza 2
- Baylor St. Luke's Medical Center, Houston
- Ben Taub Hospital (Harris Health Systems), Houston
Cultural Tailoring and Pilot Testing of an Inpatient Yoga Therapy Program for Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation in India, Tanzania, and the United States
Prebieha nábor
- M D Anderson Cancer Center, Houston
Primary Tumor Research and Outcomes Network
Prebieha náborObservačná štúdia
- The University of Texas M.D. Anderson Cancer Center, Houston
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Prebieha nábor
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
A Study of YL242 in Subjects With Advanced Solid Tumors
Prebieha náborFáza 1/2
- US-203, Houston
Spiritual Care or Psychotherapy Versus Palliative Care Alone in Patients With Non-Curative Malignancies
Prebieha náborFáza 3
- Houston Methodist Neal Cancer Center, Houston
A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.
Prebieha náborFáza 1
- The University of Texas MD Anderson Cancer Center, Houston
Targeted Therapy to Increase RAI Uptake in Metastatic DTC
Prebieha náborObservačná štúdia
- MD Anderson Cancer Center, Houston
- Texas Children's Hospital, Houston
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
Prebieha náborFáza 2
- MD Anderson Cancer Center, Houston
Childhood Cancer Predisposition Study (CCPS)
Prebieha náborObservačná štúdia
- Baylor College of Medicine, Houston
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Prebieha náborObservačná štúdia
- Massive Bio SYNERGY-AI site, Houston
A Prospective Registry to Enable Collection of Standardized Routine Care Oncology Patient Data
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- Oncology Consultants, P.A., Houston
Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer
Prebieha nábor
- Baylor College of Medicine- McNair Campus, Houston
- Baylor College of Medicine, Houston
- Ben Taub General Hospital, Houston
- a 1 ďalších
Endoscopic Ultrasound Radiofrequency Ablation and Immunotherapy Pembrolizumab for Locally Advanced Unresectable and Metastatic Pancreatic Duct Adenocarcinoma
Prebieha náborFáza 2
- The University of Texas Health Science Center at Houston, Houston
A Study of NX-1607 in Adults With Advanced Malignancies
Prebieha náborFáza 1
- MD Anderson Cancer Center, Houston
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
Prebieha náborFáza 1/2
- MD Anderson Cancer Center, Houston
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
Prebieha náborFáza 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Trial of DFP-14927 in Advanced Solid Tumors
Prebieha náborFáza 1
- MD Anderson Cancer Center, Houston
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
Prebieha náborFáza 1/2
- Oncology Consultants, P.A., Houston
- The University of Texas M. D. Anderson Cancer Center, Houston
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Prebieha nábor
- The University of Texas MD Anderson Cancer Center, Houston
HPV Vaccine, Imiquimod, and Metformin Combination Trial
Prebieha náborFáza 2
- Baylor St. Luke's Medical Center- Dan L. Duncan Comprehensive Cancer Center, Houston
- Harris Health Smith Clinic, Houston
A Study in Patients With Advanced Cancers
Prebieha náborFáza 1/2
- University of Texas MD Anderson Cancer Center, Houston
Štúdie Rakovina (všetky typy) v iných mestách
- New York City, NY109 štúdií
- Boston, MA85 štúdií
- Los Angeles, CA74 štúdií
- Nashville, TN65 štúdií
- Philadelphia, PA59 štúdií
- Washington, DC58 štúdií
- Durham, NC58 štúdií
- Chicago, IL51 štúdií
- Atlanta, GA49 štúdií
- Seattle, WA49 štúdií
- Arlington, VA48 štúdií
- St. Louis, MO46 štúdií
Iné štúdie v Houston
- Nemalobunkový karcinóm pľúc145 štúdií
- Rakovina prsníka126 štúdií
- Metastatická rakovina104 štúdií
- Kolorektálny karcinóm102 štúdií
- Rakovina vaječníkov89 štúdií
- Akútna myeloidná leukémia85 štúdií
- Rakovina pľúc78 štúdií
- Rakovina prostaty76 štúdií
- Rakovina endometria68 štúdií
- Rakovina pankreasu61 štúdií
- Melanóm59 štúdií
- Skvamóznocelulárny karcinóm hlavy a krku47 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.